Use of GLP-1 drugs early in pregnancy should not cause alarm, analysis suggests
- Posted on June 8, 2026
- By Bing News
- 0 Views
- 1 min read
Use of GLP-1 drugs early in pregnancy should not cause alarm, analysis suggests
By Nancy Lapid June 8 (Reuters) - Use of GLP-1 drugs for diabetes or obesity early in the first trimester of pregnancy, before a woman realizes she is pregnant, is not a cause for alarm, a large new data analysis suggests. These medications, which include Novo Nordisk’s semaglutide, sold as Ozempic and Wegovy, and Eli Lilly’s tirzepatide, sold as Zepbound and Mounjaro, are not recommended for
